IMPORTANT MESSAGE
Like many other companies and institutions around the world, we are experiencing interference with some of our systems within the TNT network.
We are implementing remediation steps as quickly as possible. We have implemented operational contingencies to continue to complete collections from customers with scheduled stops. For customers who do not have a regular stop, collection should be arranged via our customer service centers.
Customers may experience delays in the transit of shipments, particularly inter-continental or non-EU European delivery, as we work to remediate our systems. Additionally, if customers do not have the facility for self-labeling, they may also experience delays.
We are not able to collect shipments of dangerous goods at this time.
We regret any inconvenience to our customers.
Clinical Supply Chain Management – Global Pharma – Phase III
Clinical Supply Chain Management – Global Pharma – Phase III
Top 20 Global Pharma Company Saves $4.95 Million in Phase III Study
A top 20 global pharma client was conducting a phase III study for a new drug product to treat Diabetes. At mid-trial, they engaged Almac's Supply Chain Management experts to devise a new optimal drug supply strategy to prevent further stock-outs. This saved the client $4.95 million per year while preventing further stock-outs.
